CIK 0001840706
- Accelerated filer
- Emerging growth company
SOPHiA GENETICS SA
Sign in to watch- Ticker
- SOPH
- Exchange
- Nasdaq
- Industry
- Services-Computer Processing & Data Preparation
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- Other
- Phone
- +41 216941060
- Business address
- LA PIECE, CH-1180, ROLLE, Switzerland, 00000
- 4 Planned sale Chief Executive Officer sold 8,500 shares at $5.09 ($43,241)
- 4 Planned sale Chief Medical Officer sold 5,000 shares at $4.82 ($24,089)
- 4 Planned sale Chief People Officer sold 380 shares at $5.20 ($1,977)
- 4 Planned sale Chief Scientific Officer sold 608 shares at $5.21 ($3,165)
- 4 Planned sale Chief Legal Officer sold 684 shares at $5.20 ($3,554)
- 4 Planned sale Chief Executive Officer sold 4,486 shares at $5.21 ($23,350)
- 4 Planned sale Chief Medical Officer sold 608 shares at $5.20 ($3,162)
- 4 Planned sale President sold 760 shares at $5.20 ($3,955)
- 4 Open-market sale Chief Sales Officer sold 33 shares at $5.08 ($168)
- 4 Planned sale Chief Scientific Officer sold 600 shares at $4.97 ($2,980)
- 4 Planned sale Chief Executive Officer sold 60,602 shares at an average $4.97 ($301,235)
- 4 Planned sale Chief Medical Officer sold 1,600 shares at $4.96 ($7,933)
- 4 Planned sale President sold 2,800 shares at $4.96 ($13,887)
- 4 Planned sale Chief Legal Officer sold 2,400 shares at $4.67 ($11,201)
- 4 Planned sale Chief Scientific Officer sold 8,120 shares at an average $4.73 ($38,374)
- 4 Planned sale Chief Executive Officer sold 16,631 shares at an average $4.73 ($78,668)
- 4 Planned sale President sold 8,129 shares at an average $4.73 ($38,445)
- 4 Planned sale Chief Medical Officer sold 8,125 shares at an average $4.73 ($38,404)
- 4 Planned sale Chief Executive Officer sold 4,750 shares at an average $4.80 ($22,797)
- 4 Planned sale President sold 4,736 shares at an average $4.80 ($22,727)
Page 5 of 8 · 156 filings